Muscle multiorgan crosstalk with MG53 as a myokine for tissue repair and regeneration is a research paper published in Current Opinion in Pharmacology (2021). On theSindex it has a DataRank of 0. It has been cited 38 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
NIAMS NIH HHS
Grant: R01 AR070752
NHLBI NIH HHS
Grant: R01 HL143000
NIA NIH HHS
Grant: R01 AG056919
National Institutes of Health
Grant: DK106394
NIGMS NIH HHS
Grant: R44 GM123887
NIAMS NIH HHS
Grant: R01 AR061385
National Institutes of Health
Grant: AR061385
NIDDK NIH HHS
Grant: R01 DK106394
National Institutes of Health
Grant: AG056919
U.S. Department of Defense
Grant: W81XWH-18-1-0787
National Institutes of Health
Grant: AR070752
National Institutes of Health
Grant: 2R44GM123887-02
Protein therapeutic to facilitate healing of chronic wounds.
National Institutes of Health
Grant: 5R01HL143000-02
Preservation and Rescue of The Lung Donor Allograft for Transplantation
The Ohio State University
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals
Additional file 2 of MG53 suppresses tumor progression and stress granule formation by modulating G3BP2 activity in non-small cell lung cancer
Additional file 1 of MG53 suppresses tumor progression and stress granule formation by modulating G3BP2 activity in non-small cell lung cancer
Additional file 3 of MG53 suppresses tumor progression and stress granule formation by modulating G3BP2 activity in non-small cell lung cancer
Additional file 3 of MG53 suppresses tumor progression and stress granule formation by modulating G3BP2 activity in non-small cell lung cancer
Additional file 1 of MG53 suppresses tumor progression and stress granule formation by modulating G3BP2 activity in non-small cell lung cancer
Additional file 2 of MG53 suppresses tumor progression and stress granule formation by modulating G3BP2 activity in non-small cell lung cancer